Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
The Dog That Didn’t Bark: ODAC Gives Nod To Three Products Despite Negative FDA Reviews
Mar 18 2024
•
By
Sue Sutter
Even though FDA briefing documents were skeptical, the proverbial dog did not bark at ODAC, where three drugs had a smooth passage. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers